Select Language
English
Spanish
French
Armenian
Chinese (Simplified)
Chinese (Traditional)
Filipino
Hindi
Korean
Persian
Punjabi
Russian
Urdu
Vietnamese
Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California Institute for Regenerative Medicine
For Researchers
FUNDING OPPORTUNITIES
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
GRANTS
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
CLINICAL RESOURCES
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
RESEARCH RESOURCES
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Executive Team
CIRM Team Leads
Our History
2024 Annual Report
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report Archive
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
All CIRM Grants
Search Filters »
Disease Focus
(All)
aa Multiple Diseases (Centers & Resoures) (14)
Age-related macular degeneration (13)
Aging (22)
Alpha Thalassemia Major (3)
Alzheimer's Disease (35)
Amyotrophic Lateral Sclerosis (59)
Anemia (10)
Angelman Syndrome (1)
Arthritis (14)
Autism (23)
Autoimmune Disorder (1)
B cell cancers (12)
Beta Thalassemia (5)
Bladder or Urinary Tract Disorder (6)
Blood Cancer (73)
Blood Disorders (114)
Bone Marrow Transplant and Viral Infection (7)
Bone or Cartilage Disease (52)
Brain Cancer (35)
Brain Injury, hypoxic, ischemic (2)
Breast Cancer (9)
Canavan Disease (1)
Cancer (167)
Cartilage defect (4)
Colon Cancer (6)
Corneal Damage (7)
COVID-19 (23)
Cystic Fibrosis (3)
Cystinosis (3)
Danon Disease (4)
Dementia (5)
Developmental Disorders (23)
Diabetes (53)
Diabetic Wounds (2)
Duchenne Muscular Dystrophy (4)
Epidermolysis Bullosa (3)
Epilepsy (12)
Fertility (13)
Genetic Disorder (41)
Hearing Loss (11)
Heart Disease (105)
Heart disease associated with Duchenne muscular dystrophy (2)
Heart failure (12)
Hemophilia A (2)
HIV-related Lymphoma (2)
HIV/AIDS (42)
Huntington's Disease (37)
Hyper IgM Syndrome (2)
Hypertension, pulmonary arterial (2)
Immune Disease (57)
Incontinence (2)
Infectious Disease (55)
Inflammatory bowel disease (1)
Intellectual Disability (5)
Intervertebral disc degeneration (2)
Intestinal Disease (16)
IPEX Syndrome (5)
Kidney Disease (17)
Kidney Failure (14)
Leukemia (10)
Leukemia, Acute Myeloid (AML) (23)
Leukocyte Adhesion Deficiency (2)
Liver Disease (22)
Lung Cancer (6)
Lung Disease, Fibrosis (5)
Lupus, Systemic Lupus Erythematosus (SLE) (2)
Melanoma (13)
Metabolic Disorders (89)
Multiple Myeloma (8)
Multiple Sclerosis (9)
Muscle Injury (3)
Muscular Dystrophy (25)
N/A (441)
Neurological Disorders (311)
Neuropathy (5)
Osteoarthritis (6)
Osteonecrosis (3)
Other (19)
Ovarian Cancer (9)
Pancreatic Cancer (4)
Parkinson's Disease (52)
Pediatrics (74)
Prostate Cancer (7)
Pulmonary Hypertension (4)
Respiratory Disorders (28)
Retinitis Pigmentosa (11)
Rett's Syndrome (7)
Sanfilippo Syndrome/MPS III (2)
Sarcoma (4)
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) (4)
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) (4)
Severe Combined Immunodeficiency, X-linked (X-SCID) (8)
Sickle Cell Disease (23)
Skeletal/Smooth Muscle disorders (45)
Skin cancer (2)
Skin Disease (19)
Solid Tumors (93)
Spina Bifida (5)
Spinal Cord Injury (42)
Spinal Muscular Atrophy (9)
Stroke (29)
Tendon/Ligament/Connective Tissue Injury or Disorder (3)
Thymic Disorder, 22q11 Deletion/DiGeorge (1)
Toxicity (7)
Trauma (10)
Traumatic Brain Injury (5)
Type 1 diabetes (21)
Vascular Disease (17)
Vision Loss (66)
Wounds, ulcers (3)
X-linked Chronic Granulomatous Disease (3)
Zika virus (3)
Institution
(All)
AcuraStem Incorporated (2)
Adjuvant Partners, LLC (1)
Adverum Biotechnologies (1)
Ali Nsair (1)
Alliance Forum Foundation (4)
Allogene Therapeutics (1)
Alto Neuroscience (1)
American Association of Blood Banks (2)
American Institute of Chemical Engineers (AIChE) (1)
Angiocrine Bioscience, Inc. (4)
Ankasa Regenerative Therapeutics, Inc. (2)
Aspen Neuroscience (2)
Aspera Biomedicines, Inc. (1)
Axent Biosciences Inc. (1)
Benjamin D. Yu (1)
Berkeley City College (2)
Biocom Institute (1)
BioEclipse Therapeutics INC. (1)
Biomedical Engineering Society (2)
BioTime, Inc. (1)
Bluebird Bio (1)
Boston Children’s Hospital (1)
Brain Mapping Foundation (2)
Brain Neurotherapy Bio (1)
BrainStorm Cell Therapeutics (1)
BrainXell Therapeutics (2)
Buck Institute for Age Research (9)
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo (4)
Cal Poly Pomona Foundation (1)
Cal State Univ, Fullerton (4)
Cal State Univ, Long Beach (3)
Cal State Univ, Sacramento (3)
Cal State Univ, San Bernadino (4)
Caladrius Biosciences (2)
Calibr (3)
Calidi Biotherapeutics, Inc. (1)
California Institute of Technology (5)
California State University San Marcos Corporation (7)
California State University, Channel Islands (3)
Calimmune, Inc. (1)
Capricor, Inc (2)
Cedars-Sinai Medical Center (45)
Cellerant Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Cellular Dynamics International (1)
Celularity Inc. (1)
Chardan (1)
Charles R. Drew University of Medicine and Science (1)
Children’s Hospital of Los Angeles (18)
Children’s Hospital of Orange County (2)
Children’s Neurobiological Solutions (CNS) Foundation (1)
City College Of San Francisco (3)
City of Hope, Beckman Research Institute (59)
Combangio, Inc. (1)
Cytonus Therapeutics, Inc. (1)
Defined Bioscience, Inc. (1)
Elpida Therapeutics (1)
Escape Therapeutics, Inc (1)
Eureka Therapeutics, Inc. (1)
EVERSANA (1)
ExCellThera Inc. (1)
Excision BioTherapeutics (1)
Fate Therapeutics, Inc. (2)
Fluidigm Corporation (2)
Forty Seven Inc. (2)
FUJIFILM Cellular Dynamics (1)
Gamma Medica-Ideas, Inc. (1)
Genascence Corporation (1)
Geron Corporation (2)
Gladstone Institutes, J. David (39)
Global Genes (1)
GMR Epigenetics (1)
Gordon Research Conferences (3)
Greenstone Biosciences, Inc. (3)
HEALIOS NA, Inc. (1)
Humacyte, Inc. (2)
Human BioMolecular Research Institute (4)
Human Organ Project (1)
Humboldt State University Sponsored Programs Foundation (4)
ImmPACT-Bio, Inc. (1)
Immune-Onc Therapeutics (1)
ImmunoCellular Therapeutics (1)
ImmunoVec (3)
Immusoft Corporation (2)
Int. Soc. for Cell Gene Ther. (1)
Intact Therapeutics, Inc. (1)
International Alliance for Biological Standardization (1)
International Society for Experimental Hematology (1)
International Society for Stem Cell Research (6)
International Symposium on Neural Regeneration, Inc. (1)
iPierian, Inc. (2)
IQVIA, Inc. (2)
Jackson Labs (1)
Jasper Therapeutics, Inc. (1)
jCyte, Inc (2)
JDRF International (2)
Juvena Therapeutics Inc. (1)
Kenai Therapeutics (1)
Keystone Symposia on Molecular and Cellular Biology (3)
La Jolla Institute for Allergy and Immunology (1)
Lineage Cell Therapeutics, Inc. (3)
Loma Linda University (2)
Ludwig Institute for Cancer Research (3)
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center (5)
Luxa Biotechnology (1)
Mahzi Therapeutics (2)
MAX BioPharma, Inc. (1)
Medeor Acquisition Corp. (1)
Midwinter Conference of Immunologists (3)
Minutia, Inc. (2)
MiraCosta College (1)
Mohammad Pashmforoush (1)
Mosaic Event Management, Inc. (1)
MyoGene Bio LLC (1)
Nammi Therapeutics, Inc. (1)
Nanotools Bioscience (1)
Navega Therapeutics (1)
Neurona Therapeutics (5)
Nexcella, Inc. (1)
Nohla Therapeutics Inc (1)
Novoglia, Inc. (2)
Numerate, Inc. (1)
OCTANe Foundation for Innovation (1)
Ocular Research Symposia Foundation, Inc. (1)
OncoMed Pharmaceuticals, Inc. (1)
Orchard Therapeutics plc (1)
Organos, Inc. (1)
Ossium Health, Inc. (1)
Palo Alto Veterans Institute for Research (6)
Parkinson’s Institute (5)
Pasadena City College (3)
Pathways to Stem Cell Science (1)
Poseida Therapeutics, Inc. (2)
Rampart Bioscience (1)
RARE-X (1)
Ray Therapeutics, INC (2)
Regencor, Inc. (1)
Regenerative Patch Technologies LLC (1)
Rejuvenate Bio (1)
Rejuvenation Technologies, Inc. (1)
Replay Holdings, Inc (1)
Research for Cure (1)
Reza Ardehali (1)
Rocket Pharmaceuticals, Inc. (3)
Rubedo Life Sciences Inc. (1)
Rumi Scientific CA (1)
RUNX1 Research Program (1)
Salk Institute for Biological Studies (25)
Samumed, LLC (1)
San Diego State University Foundation (5)
San Francisco State University (4)
SanBio, Inc. (1)
Sanford Burnham Prebys Medical Discovery Institute (28)
Sanford Consortium for Regenerative Medicine (8)
Sangamo BioSciences, Inc. (2)
Scaled Biolabs Inc. (1)
Scripps Health (5)
Scripps Research Institute (31)
Semma Therapeutics (1)
Senti Biosciences, Inc. (1)
Siren Biotechnology, Inc. (1)
SJSU Research Foundation (3)
Solano Community College (1)
St. Jude Children’s Research Hospital (1)
Stanford University (179)
StemCells, Inc. (3)
Summit for Stem Cell Foundation (1)
SynGAP Research Fund (1)
Tachyon Therapeutics, Inc (1)
Tenaya Therapeutics, Inc. (1)
The American Society of Gene & Cell Therapy (1)
The Biomedical Engineering Society (1)
The Regents of the University of California on behalf of its Riverside Campus (11)
The Scintillon Institute (2)
The Stone Research Foundation for Sports Medicine and Arthritis (1)
The University Corporation at California State University, Northridge (4)
Tippi C. Mackenzie (1)
Tr1X Inc. (1)
TriFoil Imaging, Inc. (1)
UCSF Benioff Children’s Hospital Oakland (8)
University of California, Berkeley (34)
University of California, Davis (77)
University of California, Irvine (72)
University of California, Los Angeles (163)
University of California, Merced (8)
University of California, San Diego (139)
University of California, San Francisco (125)
University of California, Santa Barbara (14)
University of California, Santa Cruz (16)
University of Southern California (53)
Vala Sciences, Inc. (1)
Vertuis Bio, Inc. (1)
ViaCyte, Inc. (9)
VistaGen Therapeutics, Inc. (1)
Vitabolus, Inc. (1)
Vitalant Research Institute (6)
VxBiosciences inc. (1)
Wake Forest University Health Sciences (1)
Western University of Health Sciences (1)
X-Therma Inc. (1)
Zenobia Therapeutics (1)
Program Type
(All)
Clinical (172)
Discovery (723)
Education (326)
Infrastructure (104)
Translation (156)
Grant Type
(All)
Accelerated Development Pathway I (1)
Accelerating Center (1)
Alpha Stem Cell Clinics (3)
Alpha Stem Cell Clinics Network Expansion (12)
Basic Biology I (12)
Basic Biology II (16)
Basic Biology III (27)
Basic Biology IV (28)
Basic Biology V (28)
Bridges (16)
Bridges (29)
Clinical Trial Stage Projects (3)
Clinical Trial Stage Projects (92)
COMPASS Training Grant (16)
Comprehensive Grant (29)
Conference (81)
Conference – 2024 CIRM Trainee Network Conference (1)
Conference – Lung Regenerative Medicine Workshop (1)
Conference – Manage a Symposium on Pluripotent Stem Cell Manufacturing (1)
Conference – Manage The 2016 Bridges And SPARK Annual Meetings (1)
Conference – Manage The Bridges Annual Meeting (4)
Conference – Manage The SPARK Annual Meeting (7)
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The Alpha Stem Cell Clinic Annual Symposium (2)
Conference – The 2020 Grantee Meeting (1)
Conference II (84)
Creativity Awards (9)
Cure Sickle Cell Initiative Clinical Trial Stage Projects (3)
Diagnostic Translational Research Projects (3)
Discovery Research Projects (12)
Discovery Research Projects (1)
Disease Team Planning (22)
Disease Team Research I (15)
Disease Team Therapy Development – Research (12)
Disease Team Therapy Development III (6)
Disease Team Therapy Planning I (19)
Early Translational from Disease Team Conversion (3)
Early Translational I (16)
Early Translational II (24)
Early Translational III (21)
Early Translational IV (14)
Foundation – Discovery Stage Research Projects (39)
Genomics Centers of Excellence Awards (R) (3)
hiPSC Derivation (1)
hPSC Repository (1)
Inception – Discovery Stage Research Projects (39)
iPSC Consortia Award (1)
Late Stage Preclinical Projects (49)
Major Facilities (12)
Manufacturing Network Grant (9)
Medical Device Translational Research Projects (1)
New Cell Lines (18)
New Faculty I (26)
New Faculty II (24)
New Faculty Physician Scientist (15)
Patent Assistance Fund Awards (8)
Preclinical Development Awards (7)
Progression Award – Discovery Stage Research Projects (8)
Quest – Discovery Stage Research Projects (144)
ReMIND – Discovery Stage ReMIND (5)
Research Leadership (14)
Research Training Grant (18)
Research Training II (17)
SEED Grant (74)
Shared Labs (34)
SPARK (18)
Strategic Partnership I (2)
Strategic Partnership II (1)
Strategic Partnership III Track A (2)
Targeted Clinical Development (1)
Therapeutic Translational Research Projects (81)
Therapeutic Translational Research Projects (1)
Tissue Collection for Disease Modeling (7)
Tool Translational Research Projects (7)
Tools and Technologies I (23)
Tools and Technologies II (20)
Tools and Technologies III (22)
Training Grant I-1 (8)
Training Grant I-2 (5)
Training Grant I-3 (3)
Translating Center (1)
Transplantation Immunology (20)
Human Stem Cell Use
(All)
Adult or Tissue Stem Cell (318)
Cancer Stem Cell (46)
Directly Reprogrammed Cell (11)
Embryonic Stem Cell (389)
iPS Cell (303)
N/A (405)
Other (11)
SCNT (2)
Somatic Cell (30)
Vital Research Opportunity (3)
Cell Line Generation
(All)
Adult or Tissue Stem Cell (61)
Cancer Stem Cell (12)
Directly Reprogrammed Cell (2)
Embryonic Stem Cell (52)
iPS Cell (133)
N/A (1048)
Other (9)
SCNT (2)
Collaborative Funder
(All)
Andalusia, Spain (1)
Australia (3)
Canada (2)
France (1)
Germany (10)
Japan (1)
NIH (3)
United Kingdom (3)
Victoria, Australia (6)
Award Status
(All)
Active (348)
Closed (1115)
Pre-Active (18)
Institution
Researcher name
Grant Type
Grant Title
Award Value
University of California, Los Angeles
Dr. Scott G Kitchen
Therapeutic Translational Research Projects
Hematopoietic Stem/Progenitor Cell-Based Chimeric Antigen Receptor Gene Therapy for HIV Infection
$6,140,723
Rejuvenation Technologies, Inc.
John Ramunas
Therapeutic Translational Research Projects
Telomerase mRNA for short telomere related pulmonary fibrosis
$3,984,942
University of Southern California
Dr. Rongfu Wang
Therapeutic Translational Research Projects
Novel T cell receptor-STEM T cell immunotherapy in lung cancer
$5,689,540
Stanford University
Walter Park
Therapeutic Translational Research Projects
Enhanced Autologous Pancreatic Islet Transplantation and Survival for Diabetes Mellitus Therapy
$6,054,165
VxBiosciences inc.
Dr. Christina Chuong
Therapeutic Translational Research Projects
Escape-Resistant Oligonucleotide Therapy (ONT) for Cytomegalovirus (CMV) Disease in Hematopoietic Stem-Cell and Solid-Organ Transplant Patients
$3,977,180
City of Hope, Beckman Research Institute
Dr Jianhua Yu
Therapeutic Translational Research Projects
Specific Targeting Hypoxia Metastatic Breast Tumor with Allogeneic Off-the-Shelf Anti-EGFR CAR NK Cells Expressing an ODD domain of HIF-1α
$6,036,002
Mahzi Therapeutics
Dr. Allyson Berent
Therapeutic Translational Research Projects
Development of a Gene Therapy for the Treatment of Pitt Hopkins Syndrome (PHS) – Translating from Animal Proof of Concept to Support Pre-IND Meeting
$3,800,760
University of California, Davis
Dr. William J Murphy
Therapeutic Translational Research Projects
Overcoming resistance to standard CD19-targeted CAR T using a novel triple antigen targeted vector
$3,869,061
University of California, San Diego
Stephanie Cherqui
Therapeutic Translational Research Projects
CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia
$4,846,579
University of Southern California
Preet M Chaudhary
Therapeutic Translational Research Projects
Next generation affinity-tuned CAR for prostate cancer
$5,805,144
University of California, Los Angeles
Dr. Donald B. Kohn PhD
Therapeutic Translational Research Projects
Autologous MPO Knock-Out Hematopoietic Stem and Progenitor Cells for Pulmonary Arterial Hypertension
$4,751,297
Ray Therapeutics, INC
Paul Bresge
Therapeutic Translational Research Projects
Optogenetic therapy for treating retinitis pigmentosa and other inherited retinal diseases
$3,999,553
University of California, Irvine
Dr. Aileen J Anderson
Therapeutic Translational Research Projects
A human neural stem cell therapeutic candidate for the treatment of chronic cervical spinal cord injury
$4,950,024
University of California, San Francisco
Arun P Wiita
Therapeutic Translational Research Projects
CD72 nanoCARs for the treatment of refractory pediatric B-cell acute lymphoblastic leukemia
$3,330,801
MyoGene Bio LLC
Dr Courtney Young
Therapeutic Translational Research Projects
Development of MyoDys45-55, a gene editing therapy for Duchenne muscular dystrophy
$3,400,000
Immusoft Corporation
Dr Robert Hayes
Therapeutic Translational Research Projects
MPS II: Plasma cell delivery of iduronate sulfatase
$3,994,676
Regencor, Inc.
PILAR RUIZ-LOZANO
Therapeutic Translational Research Projects
IND-enabling Studies of Wearable Evolve-FSTL1 for Cardiac Regeneration after MI
$3,923,191
University of California, San Francisco
Dr. Hideho Okada
Therapeutic Translational Research Projects
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma
$4,556,536
ImmunoVec
Luke Riggan
Therapeutic Translational Research Projects
Hematopoietic Stem Cell Gene Therapy for IPEX Syndrome
$3,551,332
University of California, Los Angeles
Dr. Arjun Deb
Therapeutic Translational Research Projects
Targeting stromal progenitors to prevent the development of heart failure
$4,714,824
Palo Alto Veterans Institute for Research
Irene Lorenzo Llorente
Therapeutic Translational Research Projects
Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia
$5,149,913
University of California, Los Angeles
Dr. Irene L. Llorente
Therapeutic Translational Research Projects
Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia
$707,754
Juvena Therapeutics Inc.
Jeremy D O’Connell
Therapeutic Translational Research Projects
Clinical Translation of hESC-derived protein therapy that positively regulates the regenerative capacity of post-natal muscle for treating DM1
$3,906,376
University of California, Los Angeles
Cristina Puig Saus
Therapeutic Translational Research Projects
CAR-Tnm cell therapy for melanoma targeting TYRP-1
$5,904,462
University of California, Los Angeles
Dr. Lili Yang
Therapeutic Translational Research Projects
HSC-Engineered Off-The-Shelf CAR-iNKT Cell Therapy for Multiple Myeloma
$5,281,199
University of California, San Francisco
Dr. Hideho Okada
Therapeutic Translational Research Projects
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma
$525,000
Sanford Burnham Prebys Medical Discovery Institute
Dr. Evan Y. Snyder
Therapeutic Translational Research Projects
Human Neural Stem Cells (hNSCs) for neuroprotection in perinatal hypoxic-ischemic brain injury (HII)-Pre-IND-enabling Studies
$4,963,684
Neurona Therapeutics
Dr. Cory R Nicholas
Therapeutic Translational Research Projects
Development of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy
$4,848,505
University of California, San Diego
Mark H Tuszynski
Therapeutic Translational Research Projects
Human Embryonic Stem Cell-Derived Neural Stem Cells for Severe Spinal Cord Injury (SCI)
$6,235,897
University of California, Los Angeles
Yvonne Y. Chen
Therapeutic Translational Research Projects
BCMA/CS1 Bispecific CAR-T Cell Therapy to Prevent Antigen Escape in Multiple Myeloma
$3,176,805
University of California, Irvine
Dr. Brian J. Cummings
Therapeutic Translational Research Projects
An optimized human neural stem cell line (hNSC) for the treatment of traumatic brain injury (TBI)
$4,804,737
City of Hope, Beckman Research Institute
Prof. Karen S Aboody M.D.
Therapeutic Translational Research Projects
Neural Stem cell-mediated oncolytic immunotherapy for ovarian cancer
$2,873,262
University of California, Los Angeles
Dr. Caroline Y. Kuo
Therapeutic Translational Research Projects
Ex Vivo Gene Editing of Human Hematopoietic Stem Cells for the Treatment of X-Linked Hyper-IgM Syndrome
$4,896,628
University of Southern California
Dr. Mark S Humayun
Therapeutic Translational Research Projects
PRPE-SF, polarized hESC-derived RPE Soluble Factors, as a Therapy for Early Stage Dry Age-related Macular Degeneration
$3,697,935
Stanford University
Dr. Theodore Leng
Therapeutic Translational Research Projects
NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration
$4,235,758
University of California, Los Angeles
Steven Schwartz
Therapeutic Translational Research Projects
Clinical Translation of Autologous Regenerative Cell Therapy for Blindness
$5,068,026
University of California, San Francisco
Dr. Karin Lindgren Gaensler
Therapeutic Translational Research Projects
Developing engineered autologous leukemia vaccines to target residual leukemic stem cells
$4,171,728
University of California, Irvine
Dr. Magdalene J Seiler
Therapeutic Translational Research Projects
Morphological and functional integration of stem cell derived retina organoid sheets into degenerating retina models
$4,769,039
Stanford University
Dr. Bertha Chen
Therapeutic Translational Research Projects
Autologous iPSC-derived smooth muscle cell therapy for treatment of urinary incontinence
$5,977,155
MAX BioPharma, Inc.
Dr. Farhad Parhami Phd, MBA
Therapeutic Translational Research Projects
Therapeutic development of Oxy200, an oxysterol with bone anabolic and anti-resorptive properties for intervention in osteoporosis
$1,400,000
University of California, San Diego
Dan S Kaufman
Therapeutic Translational Research Projects
Human Embryonic Stem Cell-Derived Natural Killer Cells for Cancer Treatment
$3,260,000
University of California, San Diego
Catriona Jamieson
Therapeutic Translational Research Projects
A Splicing Modulator Targeting Cancer Stem Cells in Acute Myeloid Leukemia
$2,511,767
Stanford University
Dr. Anthony E. Oro
Therapeutic Translational Research Projects
DEBCT: Genetically Corrected, Induced Pluripotent Cell-Derived Epithelial Sheets for Definitive Treatment of Dystrophic Epidermolysis Bullosa
$5,107,353
University of California, San Diego
Ezra Cohen
Therapeutic Translational Research Projects
Development of ROR1 CAR-T cells to target cancer stem cells in advanced malignancies
$5,795,584
University of California, San Diego
Dr Karen Christman
Therapeutic Translational Research Projects
Injectable pro-regenerative scaffold for treating symptomatic peripheral artery disease
$2,839,317
Gladstone Institutes, J. David
Dr. Yadong Huang
Therapeutic Translational Research Projects
Human iPSC-derived GABAergic Progenitors for Alzheimer’s Disease Treatment
$1,900,000
University of California, San Francisco
Mark C. Walters M.D.
Therapeutic Translational Research Projects
Curing Sickle cell Disease with CRISPR-Cas9 genome editing
$60,635
UCSF Benioff Children’s Hospital Oakland
Dr. Mark C. Walters M.D.
Therapeutic Translational Research Projects
Curing Sickle cell Disease with CRISPR-Cas9 genome editing
$4,394,276
University of Southern California
Dr. Denis A Evseenko Dr.
Therapeutic Translational Research Projects
Pluripotent stem cell-derived chondrocytes for articular cartilage repair
$2,503,104
Ankasa Regenerative Therapeutics, Inc.
Ying Zhu
Therapeutic Translational Research Projects
An autologous somatic stem cell therapy for the treatment of osteonecrosis
$2,088,780
« Previous
1
…
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Next »